Tag: pruritus therapeutics market forecast

  • Comprehensive Pruritus Therapeutics Market Analysis 2024: Size, Share, And Key Trends

    Comprehensive Pruritus Therapeutics Market Analysis 2024: Size, Share, And Key Trends

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What Growth Rate Can Be Expected in the Pruritus Therapeutics Market from 2024 Through 2033?

    The market size for pruritus therapeutics has seen a solid surge in the past few years. With a compounded annual growth rate (CAGR) of 5.6%, it’s expected to increase from $11.39 billion in 2023 to $12.03 billion in 2024. The historical growth can be traced back to factors such as increased incidence of pruritus, a variety of causes and conditions, an aging population, and a concentration on patient’s quality of life.

    In the upcoming years, the pruritus therapeutics market is predicted to witness robust growth, escalating to $14.99 billion in 2028 at a compound annual growth rate (CAGR) of 5.6%. Factors contributing to the growth during the forecast period include enhanced understanding of the pathophysiology of pruritus, advancements in drug formulations, an inclination towards personalized medicine, an increase in dermatological research, rising awareness and diagnosis rate, and a burgeoning interest in botanical and herbal treatments. The forecast period will also see major trends such as the development of itch-specific receptor agonist and antagonists, a market focus on personalized therapy strategies, technological integration in itch tracking and treatment, and collaborative efforts for interdisciplinary research.

    Claim Your Free Sample of the Global Pruritus Therapeutics Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=11907&type=smp

    What Dynamics Are Shaping the Growth of the pruritus therapeutics Market?

    The pruritus therapeutics market is projected to grow in response to the increasing prevalence of dermatological disorders. These disorders pertain to abnormalities with the skin, hair, nail, and mucous membrane, which may range from common conditions like acne and eczema to severe ones like skin cancer and fungal infections. The type of pruritus treatment selected often depends on the root cause of the itchiness encountered in these dermatological diseases. Typical treatments include topical applications, emollients and moisturizers, immunosuppressant drugs, and medicines to alleviate itching. For instance, the American Cancer Society Inc., a voluntary organization devoted to cancer awareness, revealed in a report in January 2022 that the projected skin cancer cases had escalated to 108,480106,110 in 2021, marking a 5.8% rise from 100,350 in 2020. Consequently, the increasing cases of dermatological disorders are fueling the expansion of the pruritus therapeutics market.

    What Are the Essential Segments of the Pruritus Therapeutics Market?

    1) By Product: Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressants, Calcineurin Inhibitors, Other Products

    2) By Route of Administration: Oral, Parenteral, Topical

    3) By Disease Type: Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, Cutaneous T-Cell, Other Disease Types

    4) By End-User: Hospitals, Clinics, Other End Users

    What Are the Defining Trends in the Evolving Pruritus Therapeutics Market?

    The burgeoning trend of product development is taking center stage in the pruritus therapeutics market. Leading corporations in this field are concentrating on innovating new products to solidify their market standing. One example of this is Fresenius Medical Care AG & Co., a German company offering products and services for kidney disease patients, who in August 2021, introduced KORSUVA (difelikefalin), aimed at reducing chronic kidney disease-associated pruritus (CKD-aP) in adults undergoing hemodialysis. This new therapeutic injection was approved by the Food and Drug Administration (FDA) for the control of moderate-to-severe pruritus in patients undergoing hemodialysis due to chronic kidney failure. It is a pioneering kappa opioid receptor (KOR) targeting the external neurological system of the human body, enhancing the safety and efficacy of treatments, diagnoses, or critical illness prevention compared to conventional approaches.

    Order Now for Fast Delivery of Your Pruritus Therapeutics Market Report!

    https://www.thebusinessresearchcompany.com/report/pruritus-therapeutics-global-market-report

    Which Regions Are Emerging as Leaders in the Pruritus Therapeutics Market?

    North America was the largest region in the pruritus treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pruritus therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Pruritus Therapeutics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the pruritus therapeutics market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Pruritus Therapeutics Market Include

    1. Pruritus Therapeutics Market Executive Summary

    2. Pruritus Therapeutics Market Segments

    3. Pruritus Therapeutics Market Size And Template Market Growth Rate

    4. Key Pruritus Therapeutics Market Trends

    5. Major Pruritus Therapeutics Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Pruritus Therapeutics Market

    26. Top Pruritus Therapeutics Companies

    27. Pruritus Therapeutics Market Opportunities And Strategies

    28. Pruritus Therapeutics Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Neurodegenerative Disorder Therapeutics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

    Antisense & RNAi Therapeutics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/antisense-and-rnai-therapeutics-global-market-report

    Digital Therapeutics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/digital-therapeutics-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • What’s The Growth Forecast For Pruritus Therapeutics Market Through 2024-2033?

    What’s The Growth Forecast For Pruritus Therapeutics Market Through 2024-2033?

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    Understanding Market Dynamics

    • The pruritus therapeutics market size has shown robust growth recently, reaching $11.39 billion in 2023.
    • Expectations indicate further expansion to $12.03 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 5.6%.
    • Historic growth is attributed to increased pruritus incidence, diverse causes and conditions, aging population, and emphasis on patient quality of life.

    Anticipating Future Trends

    • Projected growth suggests a climb to $14.99 billion by 2028, maintaining a CAGR of 5.6%.
    • Foreseen drivers include enhanced understanding of pruritus pathophysiology, innovative drug formulations and delivery methods, personalized medicine focus, and intensified dermatological research and development.
    • Rising awareness, diagnosis rates, and interest in botanical remedies also contribute to this growth.

    View More On The Pruritus Therapeutics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/pruritus-therapeutics-global-market-report

    Surge In Dermatological Disorders Fuels Pruritus Therapeutics Market Growth
    Understanding Dermatological Disorders

    • Incidence of dermatological disorders is on the rise, ranging from acne to skin cancer and fungal infections.
    • Itching, a common symptom, necessitates pruritus treatments tailored to each condition, including topical treatments, immunosuppressants, and moisturizers.
    • Skin cancer cases increased by 5.8% in 2021, indicating the growing need for pruritus therapeutics.

    Key Players and Market Impact

    • Major companies like Pfizer Inc., Johnson & Johnson, and AbbVie Inc. dominate the pruritus therapeutics market.
    • Their contributions in research, development, and production of pruritus treatments significantly impact market growth and innovation.

    Innovative Therapies Drive Progress In Pruritus Treatment
    Focus on Product Innovation

    • Product innovation emerges as a crucial trend in the pruritus therapeutics market.
    • Companies strive to develop novel treatments to solidify their market presence and address unmet medical needs.

    Case Study: Fresenius Medical Care AG & Co.

    • In August 2021, Fresenius Medical Care AG & Co. introduced KORSUVA (difelikefalin), targeting pruritus related to chronic kidney dysfunction.
    • This novel therapy, approved by the FDA, demonstrates the potential of innovative treatments in addressing specific pruritus conditions.

    Strategic Acquisition Expands Ipsen’s Reach In Pruritus Treatment Landscape
    Influence of Strategic Acquisitions

    • Ipsen’s acquisition of Albireo Pharma Inc. in March 2023 signifies strategic expansion in the pruritus treatment landscape.
    • This move enriches Ipsen’s portfolio, offering promising medicines for pediatric and adult uncommon cholestatic liver disorders.

    Segmentation Overview

    • The pruritus therapeutics market is segmented by product, route of administration, disease type, and end-user.
    • This segmentation allows for targeted approaches in treatment and market strategies.

    Conclusion: Navigating the Growth Avenues
    Regional Insights

    • North America dominated the pruritus treatment market in 2023, while Asia-Pacific is poised for rapid growth in the forecast period.
    • These regional dynamics shape market strategies and investment opportunities.

    Future Prospects

    • With continued innovation, strategic acquisitions, and market segmentation, the pruritus therapeutics market presents promising growth prospects.
    • Collaboration, technological integration, and personalized approaches will further enhance treatment efficacy and patient outcomes.

    Request A Sample Of The Global Pruritus Therapeutics Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=11907&type=smp